Clinical Trial Update: A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML [Phase 2]

View source ↗

Summary

Phase 2 global trial evaluating midostaurin combined with chemotherapy in newly diagnosed pediatric patients with FLT3-mutated acute myeloid leukemia to assess …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Midostaurin (midostaurin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: FLT3-mutated Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING